About Omkar Pharmachem Limited
Data last updated: 31 December 2025
Omkar Pharmachem Limited is a public limited company based in Ahmedabad, Gujarat, India. It specialises in pharmaceutical retail and distribution, a part of the broader pharmaceuticals sector. Incorporated on 31 March 1995, the company has been in operation for over 31 years.
Registered with ROC Ahmedabad under CIN L93000GJ1995PLC025276. Listed on BSE: 532167.
Capital: an authorised share capital of ₹10.5 Cr and a paid-up capital of ₹10.08 Cr. It is led by directors including Bhawani Shankar Goyal and Anupam Kumar Mishra.
Last AGM: 24 September 2025. Financial statements filed for year ended 31 March 2025. Office: 310 Wall Street – 1 Near Gujarat College Cross Road Ellisbr, Idge, Ahmedabad, Gujarat, India – 380006.
As per the financials filed for FY 2025, the company reported a revenue of ₹54.22 Lakh, a growth of 0% compared to the previous year.
As per MCA filings, the company has satisfied charges of ₹10.89 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website omkarpharmachem.co.in.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered Address310 Wall Street – 1 Near Gujarat College Cross Road Ellisbr, Idge, Ahmedabad, Gujarat, India – 380006
-
IndustryPharma, Pharmaceutical Retailers & Distributors
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Omkar Pharmachem Limited
Omkar Pharmachem Limited has one previous CIN (Corporate Identification Number): L24231GJ1995PLC025276. The current CIN is L93000GJ1995PLC025276, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L93000GJ1995PLC025276 | Current |
| L24231GJ1995PLC025276 | Previous |
Business Activity of Omkar Pharmachem Limited
Omkar Pharmachem Limited is engaged in the principal business activity of support service to organizations, with detailed activities including other support services to organizations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations | ********* |
Auditor Details of Omkar Pharmachem Limited
Omkar Pharmachem Limited is audited by Dipal R Shah & Co. (ICAI peer reviewed, certificate valid till 2026-08-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| Dipal R Shah & Co. (ICAI peer reviewed, certificate valid till 2026-08-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Omkar Pharmachem Limited
Omkar Pharmachem Limited is currently managed by 8 directors, with 16 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhawani Shankar Goyal | Managing Director | 14 Feb 2020 | 6 Years 4 Months | Current |
|
Anupam Kumar Mishra
Also directs:
Omkar Pharmachem Limited
|
Director | 27 Aug 2025 | 0 Years 10 Months | Current |
| Surjeet Kaur | Director | 28 Jun 2025 | 1 Years 0 Months | Current |
|
Janak Raj Sharma
Also directs:
Omkar Pharmachem Limited
|
Director | 13 Feb 2016 | 10 Years 4 Months | Current |
|
Parminder Sharma
Also directs:
Omkar Pharmachem Limited, Wave Infradevelopers Private Limited, Opportunity Developers Private Limited and 2 more
|
Director | 14 Nov 2003 | 22 Years 7 Months | Current |
Financials of Omkar Pharmachem Limited FY 2026 filings available
Omkar Pharmachem Limited reported revenue of ₹46.5 Lakh (down 13.89% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹46.5 Lakh | ₹54 Lakh | ₹54 Lakh | ₹54 Lakh | ₹54 Lakh | ₹27 Lakh | ₹4.5 Lakh | ₹0 |
| Other Income | ₹74,000 | ₹22,000 | ₹35,000 | ₹30,000 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Income | ₹47.24 Lakh | ₹54.22 Lakh | ₹54.35 Lakh | ₹54.3 Lakh | ₹54 Lakh | ₹27 Lakh | ₹4.5 Lakh | ₹0 |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹20.86 Lakh | ₹16.07 Lakh | ₹15.79 Lakh | ₹13.87 Lakh | ₹17.49 Lakh | ₹15.16 Lakh | ₹15.27 Lakh | ₹19.06 Lakh |
| Finance Costs | ₹21,000 | ₹1.71 Lakh | ₹2.91 Lakh | ₹4.63 Lakh | ₹5.58 Lakh | ₹5.67 Lakh | ₹5.33 Lakh | ₹3.74 Lakh |
| Depreciation & Amortisation | ₹33,000 | ₹51,000 | ₹49,000 | ₹27,000 | ₹19,000 | ₹10,000 | ₹19,000 | ₹35,000 |
| Other Expenses | ₹9.56 Lakh | ₹8.93 Lakh | ₹9.88 Lakh | ₹9.08 Lakh | ₹9.69 Lakh | ₹9.66 Lakh | ₹9.67 Lakh | ₹18.91 Lakh |
| Total Expenses | ₹30.96 Lakh | ₹27.22 Lakh | ₹29.07 Lakh | ₹27.85 Lakh | ₹32.95 Lakh | ₹30.59 Lakh | ₹30.46 Lakh | ₹42.06 Lakh |
| Profit Before Exceptional Items & Tax | ₹16.28 Lakh | ₹27 Lakh | ₹25.28 Lakh | ₹26.45 Lakh | ₹21.05 Lakh | -₹3.59 Lakh | -₹25.96 Lakh | -₹42.06 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹16.28 Lakh | ₹27 Lakh | ₹25.28 Lakh | ₹26.45 Lakh | ₹21.05 Lakh | -₹3.59 Lakh | -₹25.96 Lakh | -₹42.06 Lakh |
| Total Tax Expense | ₹4.1 Lakh | ₹6.91 Lakh | ₹6.37 Lakh | ₹6.67 Lakh | ₹2.74 Lakh | -₹25.73 Lakh | ₹0 | -₹4,000 |
| Net Profit | ₹12.18 Lakh | ₹20.09 Lakh | ₹18.91 Lakh | ₹19.78 Lakh | ₹18.31 Lakh | ₹22.14 Lakh | -₹25.96 Lakh | -₹42.02 Lakh |
| Other Comprehensive Income | ₹27.08 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹27.21 Cr | ₹20.09 Lakh | ₹18.91 Lakh | ₹19.78 Lakh | ₹18.31 Lakh | ₹22.14 Lakh | -₹25.96 Lakh | -₹42.02 Lakh |
| EBITDA (computed) | ₹16.82 Lakh | ₹29.22 Lakh | ₹28.68 Lakh | ₹31.35 Lakh | ₹26.82 Lakh | ₹2.18 Lakh | -₹20.44 Lakh | -₹37.97 Lakh |
| Basic EPS | ₹26.98 | ₹0.20 | ₹0.19 | ₹0.20 | ₹0.18 | ₹0.21 | ₹-0.26 | ₹-0.42 |
| Diluted EPS | ₹26.98 | ₹0.20 | ₹0.19 | ₹0.20 | ₹0.18 | ₹0.21 | ₹-0.26 | ₹-0.42 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹36.69 Cr | ₹9.6 Cr | ₹9.59 Cr | ₹9.73 Cr | ₹9.83 Cr | ₹9.63 Cr | ₹9.36 Cr | ₹9.32 Cr |
| Non-current Assets | ₹36.39 Cr | ₹9.34 Cr | ₹9.41 Cr | ₹9.47 Cr | ₹9.54 Cr | ₹9.56 Cr | ₹9.3 Cr | ₹9.3 Cr |
| Current Assets | ₹30.14 Lakh | ₹26.51 Lakh | ₹18.41 Lakh | ₹26.23 Lakh | ₹29.24 Lakh | ₹7.09 Lakh | ₹5.88 Lakh | ₹2.03 Lakh |
| Property, Plant & Equipment | ₹37,000 | ₹70,000 | ₹81,000 | ₹37,000 | ₹64,000 | ₹15,000 | ₹25,000 | ₹30,000 |
| Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Trade Receivables | ₹3.24 Lakh | ₹9.72 Lakh | ₹4.76 Lakh | ₹12.96 Lakh | ₹8.1 Lakh | ₹2.7 Lakh | ₹1.8 Lakh | ₹0 |
| Cash & Equivalents | ₹21.73 Lakh | ₹10.94 Lakh | ₹7.16 Lakh | ₹13.27 Lakh | ₹21.14 Lakh | ₹4.39 Lakh | ₹4.08 Lakh | ₹2.03 Lakh |
| Equity (Net Worth) | ₹36.64 Cr | ₹9.43 Cr | ₹9.23 Cr | ₹9.04 Cr | ₹8.85 Cr | ₹8.66 Cr | ₹8.44 Cr | ₹8.7 Cr |
| Equity Share Capital | ₹10.08 Cr | ₹10.08 Cr | ₹10.08 Cr | ₹10.08 Cr | ₹10.08 Cr | ₹10.08 Cr | ₹10.08 Cr | ₹10.08 Cr |
| Borrowings (Non-current) | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Borrowings (Current) | ₹0 | ₹11.85 Lakh | ₹30.31 Lakh | ₹62.14 Lakh | ₹92.97 Lakh | ₹90.24 Lakh | ₹86.55 Lakh | ₹57.73 Lakh |
| Total Debt (computed) | ₹0 | ₹11.85 Lakh | ₹30.31 Lakh | ₹62.14 Lakh | ₹92.97 Lakh | ₹90.24 Lakh | ₹86.55 Lakh | ₹57.73 Lakh |
| Current Liabilities | ₹5.06 Lakh | ₹16.96 Lakh | ₹35.53 Lakh | ₹68.62 Lakh | ₹98.36 Lakh | ₹96.76 Lakh | ₹92.06 Lakh | ₹62.29 Lakh |
| Total Liabilities | ₹5.06 Lakh | ₹16.96 Lakh | ₹35.96 Lakh | ₹68.62 Lakh | ₹98.36 Lakh | ₹96.76 Lakh | ₹92.06 Lakh | ₹62.29 Lakh |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹22.85 Lakh | ₹24.35 Lakh | ₹29.56 Lakh | ₹27.59 Lakh | ₹20.28 Lakh |
| Investing Cash Flow | ₹0 | -₹40,000 | -₹93,000 | ₹0 | -₹68,000 |
| Financing Cash Flow | -₹12.06 Lakh | -₹20.17 Lakh | -₹34.74 Lakh | -₹35.46 Lakh | -₹2.85 Lakh |
| Capital Expenditure | ₹0 | ₹40,000 | ₹93,000 | ₹0 | ₹68,000 |
| Free Cash Flow (computed) | ₹22.85 Lakh | ₹23.95 Lakh | ₹28.63 Lakh | ₹27.59 Lakh | ₹19.6 Lakh |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | ₹10.79 Lakh | ₹3.78 Lakh | -₹6.11 Lakh | -₹7.87 Lakh | ₹16.75 Lakh |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹9 Lakh | ₹10.5 Lakh | ₹13.5 Lakh | ₹13.5 Lakh | ₹13.5 Lakh | ₹13.5 Lakh | ₹13.5 Lakh | ₹13.5 Lakh |
| Other Income | ₹30,000 | ₹0 | ₹44,000 | ₹0 | ₹0 | ₹22,000 | ₹0 | ₹0 |
| Total Income | ₹9.3 Lakh | ₹10.5 Lakh | ₹13.94 Lakh | ₹13.5 Lakh | ₹13.5 Lakh | ₹13.72 Lakh | ₹13.5 Lakh | ₹13.5 Lakh |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹5.14 Lakh | ₹5.43 Lakh | ₹5.36 Lakh | ₹4.93 Lakh | ₹4.72 Lakh | ₹4.2 Lakh | ₹3.37 Lakh | ₹3.78 Lakh |
| Finance Costs | ₹0 | ₹0 | ₹21,000 | ₹0 | ₹1.71 Lakh | ₹0 | ₹0 | ₹0 |
| Depreciation & Amortisation | ₹8,000 | ₹8,000 | ₹8,000 | ₹8,000 | ₹15,000 | ₹15,000 | ₹12,000 | ₹9,000 |
| Other Expenses | ₹2.13 Lakh | ₹1.03 Lakh | ₹1.49 Lakh | ₹4.91 Lakh | ₹2.16 Lakh | ₹88,000 | ₹1.16 Lakh | ₹4.73 Lakh |
| Total Expenses | ₹7.35 Lakh | ₹6.54 Lakh | ₹7.14 Lakh | ₹9.92 Lakh | ₹8.74 Lakh | ₹5.23 Lakh | ₹4.65 Lakh | ₹8.6 Lakh |
| Profit Before Exceptional Items & Tax | ₹1.95 Lakh | ₹3.96 Lakh | ₹6.8 Lakh | ₹3.58 Lakh | ₹4.76 Lakh | ₹8.49 Lakh | ₹8.85 Lakh | ₹4.9 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹1.95 Lakh | ₹3.96 Lakh | ₹6.8 Lakh | ₹3.58 Lakh | ₹4.76 Lakh | ₹8.49 Lakh | ₹8.85 Lakh | ₹4.9 Lakh |
| Total Tax Expense | ₹45,000 | ₹1.01 Lakh | ₹1.73 Lakh | ₹92,000 | ₹6.91 Lakh | ₹0 | ₹0 | ₹0 |
| Net Profit | ₹1.5 Lakh | ₹2.95 Lakh | ₹5.07 Lakh | ₹2.66 Lakh | -₹2.15 Lakh | ₹8.49 Lakh | ₹8.85 Lakh | ₹4.9 Lakh |
| Other Comprehensive Income | ₹27.08 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹27.1 Cr | ₹2.95 Lakh | ₹5.07 Lakh | ₹2.66 Lakh | -₹2.15 Lakh | ₹8.49 Lakh | ₹8.85 Lakh | ₹4.9 Lakh |
| EBITDA (computed) | ₹2.03 Lakh | ₹4.04 Lakh | ₹7.09 Lakh | ₹3.66 Lakh | ₹6.62 Lakh | ₹8.64 Lakh | ₹8.97 Lakh | ₹4.99 Lakh |
| Basic EPS | ₹26.87 | ₹0.03 | ₹0.05 | ₹0.02 | ₹-0.02 | ₹0.08 | ₹0.09 | ₹0.05 |
| Diluted EPS | ₹26.87 | ₹0.03 | ₹0.05 | ₹0.02 | ₹-0.02 | ₹0.08 | ₹0.09 | ₹0.05 |
Shareholding Pattern of Omkar Pharmachem Limited
As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 0.03%, retail and other public shareholders hold 99.97% of Omkar Pharmachem Limited. The company had 3,617 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% |
| Public | 99.97% | 99.97% | 99.97% | 99.97% | 99.97% | 99.97% |
| Mar 2026 | Mar 2025 | Mar 2024 | |
|---|---|---|---|
| Promoters | 0.03% | 0.03% | 0.03% |
| Public | 99.97% | 99.97% | 99.97% |
| Promoter change (YoY, %pts) | +0.00 | +0.00 | - |
Charges & Borrowings of Omkar Pharmachem Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 May 1995 | Gujarat State Financial Co-Op | ₹10.89 Lakh | Satisfied |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Omkar Pharmachem Limited
View historical data on people associated with Omkar Pharmachem Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Omkar Pharmachem Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Omkar Pharmachem Limited
GSTIN & GST Filing Data of Omkar Pharmachem Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Omkar Pharmachem Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Omkar Pharmachem Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Omkar Pharmachem Limited
MSME Payment Delays by Omkar Pharmachem Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Omkar Pharmachem Limited
Subsidiaries & Group Companies of Omkar Pharmachem Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Omkar Pharmachem Limited with ownership details.
MCA Filings & Documents of Omkar Pharmachem Limited
MCA Filings & Documents of Omkar Pharmachem Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Omkar Pharmachem Limited
Frequently Asked Questions about Omkar Pharmachem Limited
Omkar Pharmachem Limited is an active public limited company in the pharma sector based in Ahmedabad, Gujarat, India. It was incorporated on 31 March 1995 (31+ years old) and is registered under CIN L93000GJ1995PLC025276. Listed on BSE: 532167.
Omkar Pharmachem Limited reported revenue of ₹54.22 Lakh for FY 2025 (up 0.00% YoY).
The current directors of Omkar Pharmachem Limited are:
- Bhawani Shankar Goyal
- Anupam Kumar Mishra
- Shivam Karotiya
- Surjeet Kaur
- Janak Raj Sharma
- Parminder Sharma
- Arun Kumar
- Pankaj Mahadeo Singh
The primary industry of Omkar Pharmachem Limited is pharma. The company specifically operates in pharmaceutical retailers and distributors. The company is currently active in this sector.
Yes. Omkar Pharmachem Limited is listed on BSE with code 532167.
Omkar Pharmachem Limited can be reached at the registered office: 310 Wall Street – 1 Near Gujarat College Cross Road Ellisbr, Idge, Ahmedabad, Gujarat, India – 380006, or through the website omkarpharmachem.co.in.